Professionally reviewed By Fiona Lai, Registered Dietitian
Butyrate, a short-chain fatty acid (SCFA), is undergoing more research studies and investigation for its role in gastrointestinal health in recent years. SCFAs are fatty acids produced by gut bacteria fermenting fiber, which fuel colon cells and impact gut health and overall metabolism (1).
This article explains what butyrate is, how it’s made, its benefits, and how it fits within the broader ecosystem of gut health alongside probiotics and prebiotics.
Short-Chain Fatty Acids: What Are They and How They Affect Gut Health
Short-chain fatty acids (SCFA)—primarily acetate, propionate, and butyrate—are the main metabolites produced when beneficial gut microbes ferment complex carbohydrates and fibers in the large intestine (1).
Each SCFA performs distinct yet complementary roles (1, 2, 3),
- Acetate fuels systemic metabolism and supports lipid synthesis.
- Propionate participates in glucose regulation and may support liver health.
- Butyrate primarily nourishes colonocytes—the epithelial cells lining the colon—providing up to 70% of their energy.
Together, these SCFAs maintain intestinal integrity, regulate pH, discourage the growth of harmful bacteria, and signal immune cells to soothe and prevent inflammation (1, 4, 5).
To generate enough SCFAs for the body, the gut needs both adequate dietary fiber intake and a healthy microbiome environment. Fiber acts as the raw material, while beneficial bacteria ferment it into SCFAs (2, 6, 7)
Without sufficient fiber or balanced gut flora, SCFA production falls, which then affect digestion, gut barrier strength, and inflammation control. Learn more about SCFA here;
The Differences Between Short-Chain Fatty Acids, Probiotics and Prebiotics
You may have heard of probiotics and prebiotics, and short-chain fatty acids (SCFAs) — but how do they work, and do they work together?
While they are interrelated and closely linked to gastrointestinal health, each plays a distinct yet interdependent role in digestive wellness:
| Component | Description | Function |
|---|---|---|
| Probiotics | Live good gut bacteria | Help maintain a balanced, well-functioning microbiome environment in the gut |
| Prebiotics | Non-digestible dietary fibers (also known as complex carbohydrates) that feed probiotics | Provide nourishment for beneficial bacteria |
| Short-Chain Fatty Acids | The byproduct of fermentation when the good gut bacteria breaks down the fibers | Energy source for the colon cells, intestinal barrier strength, regulates inflammation and immune system |
In short, probiotics and prebiotics create the foundation, while SCFAs such as butyrate are then produced to deliver gut health benefits — completing the cycle of a healthy, well-functioning gut ecosystem. Learn more about the differences here:
Among types of short chain fatty acids, Butyrate is found to be the preferred energy source for colon cells (which provides up to 70% energy of total cell needs) and has anti-inflammatory properties in the gut (8).
er-rich foods such as fruits, vegetables, whole grains, and legumes helps increase the production of short-chain fatty acids (SCFAs) in the colon (2, 9).
Studies show that a higher fiber intake enhances butyrate production, while a low-fiber diet can significantly reduce it (10).
The following types of dietary fiber are especially beneficial for stimulating SCFA — including butyrate — production (11, 12, 13, 14):
- Inulin: Found in artichokes, garlic, leeks, onions, wheat, rye, and asparagus. It’s also a common type of prebiotic supplement.
- Fructooligosaccharides (FOS): Present in bananas, onions, garlic, and asparagus, also another common type of prebiotic supplement.
- Guar Gum: Derived from guar beans. Also available as partially hydrolysed guar gum supplements (PHGG).
- Resistant Starch: Found in cooled cooked potatoes, rice, barley, beans, and green bananas.
- Pectin: Present in apples, apricots, carrots, and citrus fruits.
- Arabinoxylan: The dominant fiber in wheat bran and other cereal grains.
Types of Butyrate Supplements: What’s Available and How They Work
Butyrate supplements offer a direct source of this vital SCFA, particularly for individuals whose gut microbiome or diet may not produce sufficient amounts.
Common forms include:
- Sodium Butyrate – Effective but contributes extra sodium, which may be undesirable for those with high blood pressure or sodium-sensitive conditions.
- Calcium Butyrate – A sodium-free alternative that combines butyrate with calcium, supporting both gut and bone health.
Recent formulations use microencapsulation technology, which shields butyrate from stomach acid so that it can reach the colon more effectively.
This targeted and sustained release ensures better absorption and reduces the unpleasant odor and taste typically associated with butyrate.
In today’s population, where sodium intake is often high, calcium butyrate is often considered a better alternative for long term usage. Learn more about Butyrate Supplements here:
Benefits of Butyrate for Gut and Colon Health:
While Butyrate shares similarities with gastrointestinal supplements such as probiotics and prebiotics, they complement each other rather than being redundant.
Probiotics help to provide beneficial “good gut” bacteria (15), prebiotics provide nourishment for these bacteria (16), while SCFA like Butyrate supports gut lining repair, reduces inflammation, regulates the immune system and more (1, 4, 5).
Hence, consuming them together can enhance overall gut health and digestive function.
Butyrate is a type of short-chain fatty acid (SFCA) that helps to support gut lining repair, reduces inflammation, regulates immune system and more (1, 4, 5).
Here are some key benefits Butyrate offers:
- Energy Source for Colonocytes: Butyrate is the primary fuel source for Colonocytes, which are the epithelial cells that form the lining of the colon’s inner surface. They play a vital role in absorbing water and electrolytes, providing a protective barrier, and utilizing short-chain fatty acids like butyrate for energy, thus contributing significantly to overall gut health, such as gut lining growth and repair, which is essential for maintaining a healthy gut. (1, 16)
- Anti-inflammatory Properties: Butyrate exhibits potent anti-inflammatory effects, helping to reduce inflammation in the gut. This is crucial for preventing and managing various gut disorders such as IBD. (1, 4, 17)
- Strengthening the Gut Barrier: Butyrate enhances the gut barrier, preventing “leaky gut”, which reduces the risk of leaking harmful substances into the bloodstream, often the cause of inflammation in the body. (1, 18, 19)
- Improved Gut Motility: Butyrate can influence gut motility, helping to regulate bowel movements and prevent constipation. (5, 20)
- pH Regulation: Butyrate helps to lower the pH of the colon, creating an environment that favours the growth of beneficial bacteria. (10)
Butyrate for Gastrointestinal Disorders:
- Irritable Bowel Syndrome (IBS): Butyrate can alleviate IBS symptoms by reducing inflammation, regulating gut motility, and improving gut barrier function. Studies have shown that butyrate supplementation may help reduce abdominal pain, bloating, and altered bowel habits in individuals with IBS. (21, 22)
- Inflammatory Bowel Disease (IBD): In conditions like Crohn’s disease and ulcerative colitis, butyrate’s anti-inflammatory properties can be particularly beneficial. It can help reduce inflammation in the gut lining, promote healing, and alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding. Research suggests that butyrate supplementation may be a valuable adjunct therapy for IBD. (17, 23, 24, 25)
- Reduction of visceral hypersensitivity: Butyrate may help reduce the hypersensitivity of the nerves in the gut, which plays a large role in the pain and discomfort associated with IBS and IBD. (21, 22, 24)
Given its mechanism of action, Butyrate can potentially alleviate symptoms of gastrointestinal disorders such as IBS and IBD.
Conclusion
Overall, Butyrate plays a major role in maintaining gut health and influencing overall well-being.
With a fiber-rich diet and butyrate supplementation, individuals can support their gut microbiome, promote colon health, and potentially alleviate symptoms of gastrointestinal disorders such as IBS and IBD.
As with any supplement, consulting with a healthcare professional is recommended before starting butyrate supplementation, especially for those with existing health conditions.
About the Reviewer
Fiona Lai is a registered dietitian of the Malaysian Dietitians’ Association (MDA), with over five years of combined professional dietetics experience in the nutraceutical industry. She specialises in nutrition advisory, product formulation and professional training for healthcare workers. A periodic guest columnist with local news media such as The Star, Fiona is passionate about translating science into practical nutrition that nurtures balanced, lasting wellness.
References :
- Canani, R. B., Costanzo, M. D., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World journal of gastroenterology, 17(12), 1519–1528. https://doi.org/10.3748/wjg.v17.i12.1519
- Koh, A., et al (2016). From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165(6), 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041
- Bose, S., Ramesh, V., & Locasale, J. W. (2019). Acetate Metabolism in Physiology, Cancer, and Beyond. Trends in cell biology, 29(9), 695–703. https://doi.org/10.1016/j.tcb.2019.05.005
- Vinolo, M. A. R., et al (2011). Regulation of inflammation by short chain fatty acids. Nutrients, 3(10), 858–876. https://doi.org/10.3390/nu3100858
- den Besten, G., et al (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, 54(9), 2325–2340. https://doi.org/10.1194/jlr.R036012
- Mueller, N. T., et al (2020). Effects of high-fiber diets enriched with carbohydrate, protein, or unsaturated fat on circulating short chain fatty acids: results from the OmniHeart randomized trial. The American journal of clinical nutrition, 111(3), 545–554. https://doi.org/10.1093/ajcn/nqz322
- Yang, Q., et al (2020). Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients, 12(2), 381. https://doi.org/10.3390/nu12020381
- Liu, H., et al(2018). Butyrate: A Double-Edged Sword for Health?. Advances in nutrition (Bethesda, Md.), 9(1), 21–29. https://doi.org/10.1093/advances/nmx009
- Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017 Mar 4;8(2):172-184. doi: 10.1080/19490976.2017.1290756. Epub 2017 Feb 6. PMID: 28165863; PMCID: PMC5390821.
- Cummings, J. H., & Macfarlane, G. T. (2002). Gastrointestinal effects of prebiotics. British Journal of Nutrition, 87(S2), S145–S151. https://doi.org/10.1079/BJN2002530
- Yang, Q., et al (2020). Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients, 12(2), 381. https://doi.org/10.3390/nu12020381
- van der Beek, et al (2018). The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism: clinical and experimental, 87, 25–35. https://doi.org/10.1016/j.metabol.2018.06.009
- Peng, M., et al (2020). Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods. Comprehensive reviews in food science and food safety, 19(4), 1908–1933. https://doi.org/10.1111/1541-4337.12565
- Green, M., Arora, K., & Prakash, S. (2020). Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. International journal of molecular sciences, 21(8), 2890. https://doi.org/10.3390/ijms21082890
- Cleveland Clinic. (n.d.). Probiotics: What they are, types & benefits. Retrieved October 2025, from https://my.clevelandclinic.org/health/articles/14598-probiotics
- Donohoe, D. R. et al (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism, 13(5), 517–526. https://doi.org/10.1016/j.cmet.2011.02.018
- Chen, J., & Vitetta, L. (2020). Butyrate in inflammatory bowel disease therapy. Correspondence, 158(5), 1511. https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2820%2930105-0
- Mishra, S. P., et al (2024). Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function. JCI insight, 9(3), e168443. https://doi.org/10.1172/jci.insight.168443
- Peng, L. et al (2009). Butyrate enhances the intestinal barrier by facilitating tight-junction assembly via activation of AMP-activated protein kinase. The Journal of Nutrition, 139(9), 1619–1625. https://doi.org/10.3945/jn.109.104638
- Zhuang, M., Shang, W., Ma, Q., Strappe, P., & Zhou, Z. (2019). Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion. Molecular nutrition & food research, 63(23), e1801187. https://doi.org/10.1002/mnfr.201801187
- Jiang, W., et al (2022). The role of short-chain fatty acids in irritable bowel syndrome. Journal of Neurogastroenterology and Motility, 28(4), 540–548. https://doi.org/10.5056/jnm22093
- Lewandowski, K., Kaniewska, M., Karłowicz, K., Rosołowski, M., & Rydzewska, G. (2022). The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Przeglad gastroenterologiczny, 17(1), 28–34. https://doi.org/10.5114/pg.2021.112681
- Di Sabatino, A. et al (2005). Oral butyrate for mildly to moderately active Crohn’s disease. Alimentary pharmacology & therapeutics, 22(9), 789–794. https://doi.org/10.1111/j.1365-2036.2005.02639.x
- Recharla, N., Geesala, R., & Shi, X. Z. (2023). Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review. Nutrients, 15(10), 2275. https://doi.org/10.3390/nu15102275
- Firoozi, D., et al (2024). Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids in health and disease, 23(1), 216. https://doi.org/10.1186/s12944-024-02203-z
